Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

European shares hover at eight-month highs as virus' economic impact weighs

Published 11/10/2020, 03:14 AM
Updated 11/10/2020, 03:55 AM
© Reuters. The German share price index DAX graph at the stock exchange in Frankfurt

© Reuters. The German share price index DAX graph at the stock exchange in Frankfurt

By Sagarika Jaisinghani

(Reuters) - European shares hovered at eight-month highs on Tuesday on optimism around signs of a breakthrough in developing a COVID-19 vaccine, although concerns about the depth of the economic damage from the pandemic capped gains.

The pan-European STOXX 600 (STOXX) was flat after rallying 4% in the previous session as U.S. drugmaker Pfizer Inc (N:PFE) said its COVID-19 vaccine, developed with German partner BioNTech SE (O:BNTX), was more than 90% effective in preventing the infection.

"The results of the Pfizer study are certainly welcome news, however, one swallow does not make a summer and there still remains some way to go before life can return to any semblance of normal," said Michael Hewson, a market analyst at CMC Markets UK.

European shares have already surged 11% this month as investors also cheered the possibility of calmer global trade under U.S. President-elect Joe Biden, but strict lockdowns to contain surging coronavirus cases have threatened a nascent economic recovery at home.

Data on Tuesday showed British employers made a record number of staff redundant in the third quarter and the jobless rate jumped. London's export-laden FTSE 100 (FTSE) was up 0.6% by 0835 GMT.

Italy's bourse (FTMIB) added 0.1% a day after posting its best day since March. The country is ramping up business restrictions in Tuscany and four other regions to rein in the second wave of the pandemic.

Banking (SX7P), travel and leisure (SXTP), and energy (SXEP) stocks were among the biggest gainers in morning trading after clocking gains of more than 7% on Monday.

"Even if a vaccine proves effective, inoculating a large enough part of the population will take time and leave these segments prone to economic lockdown fallout," Commerzbank (DE:CBKG) analyst Christoph Rieger said.

Investor attention has also been on Brexit trade talks with Britain's transition period set to expire by the end of the year. UK Prime Minister Boris Johnson suffered a heavy defeat in parliament's upper chamber on Monday over proposed laws which would allow him to breach the exit treaty.

Focus later in the day will be on a reading of the German investor sentiment for November. Economists expect sentiment to have ticked lower following a bigger-than-expected slump in October.

In company news, shares of shopping mall owner Unibail-Rodamco-Westfield (AS:URW) surged 28.4% to the top of the STOXX 600 after its shareholders voted against a planned 3.5 billion euro ($4.15 billion) rights issue.

© Reuters. The German share price index DAX graph at the stock exchange in Frankfurt

German sportswear firm Adidas (DE:ADSGn) lost 2.5% even as it said it expects sales to return to growth in China in the fourth quarter.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.